Healthcare provider profile · identity verified

Darshan Patel, MD

Hospitalist · CORTLAND, NY · NPI 1962662957

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Fluconazole	Fluconazole	204	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	160	35
Eliquis	Apixaban	149	21
Furosemide	Furosemide	149	38
Citalopram Hbr	Citalopram Hydrobromide	139	25
Sertraline Hcl	Sertraline Hcl	119	23
Xarelto	Rivaroxaban	116	suppressed
Atorvastatin Calcium	Atorvastatin Calcium	115	33
Pantoprazole Sodium	Pantoprazole Sodium	107	21
Potassium Chloride	Potassium Chloride	91	18
Gabapentin	Gabapentin	90	20
Metoprolol Succinate	Metoprolol Succinate	87	15
Amlodipine Besylate	Amlodipine Besylate	86	19
Carbidopa-Levodopa	Carbidopa/Levodopa	85	12
Quetiapine Fumarate	Quetiapine Fumarate	85	23
Lisinopril	Lisinopril	78	11
Warfarin Sodium	Warfarin Sodium	77	suppressed
Lorazepam	Lorazepam	75	29
Metoprolol Tartrate	Metoprolol Tartrate	62	21
Risperidone	Risperidone	57	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	56	11
Clopidogrel	Clopidogrel Bisulfate	55	11
Metformin Hcl	Metformin Hcl	55	14
Losartan Potassium	Losartan Potassium	46	13
Montelukast Sodium	Montelukast Sodium	44	suppressed
Carbamazepine	Carbamazepine	43	suppressed
Famotidine	Famotidine	43	12
Doxycycline Hyclate	Doxycycline Hyclate	42	25
Tamsulosin Hcl	Tamsulosin Hcl	41	14
Omeprazole	Omeprazole	40	suppressed
Tramadol Hcl	Tramadol Hcl	38	suppressed
Cephalexin	Cephalexin	37	18
Digoxin	Digoxin	37	suppressed
Levetiracetam	Levetiracetam	36	suppressed
Spironolactone	Spironolactone	36	suppressed
Alendronate Sodium	Alendronate Sodium	34	suppressed
Baclofen	Baclofen	34	suppressed
Divalproex Sodium	Divalproex Sodium	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Latanoprost	Latanoprost	33	suppressed
Memantine Hcl	Memantine Hcl	33	suppressed
Glipizide	Glipizide	32	suppressed
Torsemide	Torsemide	32	suppressed
Amiodarone Hcl	Amiodarone Hcl	31	suppressed
Carvedilol	Carvedilol	27	suppressed
Atenolol	Atenolol	26	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	26	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Clindamycin Hcl	Clindamycin Hcl	24	11
Flecainide Acetate	Flecainide Acetate	24	suppressed
Nuplazid	Pimavanserin Tartrate	24	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Prednisone	Prednisone	24	14
Rexulti	Brexpiprazole	24	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	23	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	23	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	11
Propranolol Hcl	Propranolol Hcl	23	suppressed
Dexamethasone	Dexamethasone	22	16
Morphine Sulfate	Morphine Sulfate	22	19
Scopolamine	Scopolamine	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	14
Midodrine Hcl	Midodrine Hcl	21	suppressed
Myrbetriq	Mirabegron	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	20	suppressed
Metolazone	Metolazone	20	suppressed
Vilazodone Hcl	Vilazodone Hcl	20	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	15
Acarbose	Acarbose	18	suppressed
Allopurinol	Allopurinol	18	suppressed
Erythromycin	Erythromycin Base	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	12
Ondansetron Odt	Ondansetron	17	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	17	13
Amantadine	Amantadine Hcl	16	suppressed
Bumetanide	Bumetanide	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Levofloxacin	Levofloxacin	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Aripiprazole	Aripiprazole	15	suppressed
Lidocaine Hcl	Lidocaine Hcl	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Simvastatin	Simvastatin	15	suppressed
Belsomra	Suvorexant	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Dilt-Xr	Diltiazem Hcl	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Rivastigmine	Rivastigmine Tartrate	14	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	13	12
Cefdinir	Cefdinir	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Insulin Lispro	Insulin Lispro	13	suppressed
Trazodone Hcl	Trazodone Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Methimazole	Methimazole	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Methenamine Hippurate	Methenamine Hippurate	11	suppressed
Nystatin	Nystatin	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error